EZH1/2 inhibition improves immunotherapy response through MHC Class II de-repression and neutrophil reprogramming.

Saved in:
Bibliographic Details
Title: EZH1/2 inhibition improves immunotherapy response through MHC Class II de-repression and neutrophil reprogramming.
Authors: Childress AR, Esoe DP, Song X, Gosser CM, Lin Y, Plaugher DR, DuCote TJ, Naughton KJ, Skaggs EM, Yang H, Goettl R, Liu J, Hao Z, Fliss AE, Honma D, Burus T, Lei F, Huang B, Beswick EJ, Brainson CF
Source: BioRxiv : the preprint server for biology [bioRxiv] 2026 Jul 02. Date of Electronic Publication: 2026 Jul 02.
Publication Type: Journal Article; Preprint
Journal Info: Country of Publication: United States NLM ID: 101680187 Publication Model: Electronic Cited Medium: Internet ISSN: 2692-8205 (Electronic) Linking ISSN: 26928205 NLM ISO Abbreviation: bioRxiv Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2692-8205
DOI:10.64898/2026.06.01.725956